1999
DOI: 10.1074/jbc.274.15.10219
|View full text |Cite
|
Sign up to set email alerts
|

Basolateral Localization of Fiber Receptors Limits Adenovirus Infection from the Apical Surface of Airway Epithelia

Abstract: Recent identification of two receptors for the adenovirus fiber protein, coxsackie B and adenovirus type 2 and 5 receptor (CAR), and the major histocompatibility complex (MHC) Class I ␣-2 domain allows the molecular basis of adenoviral infection to be investigated. Earlier work has shown that human airway epithelia are resistant to infection by adenovirus. Therefore, we examined the expression and localization of CAR and MHC Class I in an in vitro model of well differentiated, ciliated human airway epithelia. … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

17
304
3
2

Year Published

2003
2003
2019
2019

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 334 publications
(326 citation statements)
references
References 55 publications
17
304
3
2
Order By: Relevance
“…After only 4 hours of treatment, we saw a significant decline in the level of occludin and JAM-A, in comparison to the time interval of 2 to 3 days before we detected a decline in CAR level. In some types of cells, such as human airway epithelia, CAR was located within the adherens junctions at the basolateral side of the columnar cell layer, rendering the cells resistant to viral infection from the apical surface [47]. Here, it is not certain whether CAR also resides near the basal side of the Sertoli cell layers as it does in human airway epithelia.…”
Section: Discussionmentioning
confidence: 99%
“…After only 4 hours of treatment, we saw a significant decline in the level of occludin and JAM-A, in comparison to the time interval of 2 to 3 days before we detected a decline in CAR level. In some types of cells, such as human airway epithelia, CAR was located within the adherens junctions at the basolateral side of the columnar cell layer, rendering the cells resistant to viral infection from the apical surface [47]. Here, it is not certain whether CAR also resides near the basal side of the Sertoli cell layers as it does in human airway epithelia.…”
Section: Discussionmentioning
confidence: 99%
“…Several studies have determined that disruption of calciumdependent intercellular junctions by EGTA improves viral infection efficiency in various tissues and polarized cell cultures. 23,25,26,28 Previous evidence demonstrated that polarized apical membranes of normal human bronchial epithelial (NHBE) airway cells are resistant to lipofection. NHBE cells form multicellular islands similar to that of long-term primary rat hepatocyte cultures maintained in DMSO.…”
Section: Discussionmentioning
confidence: 99%
“…24 Several studies have determined that disruption of calcium-dependent paracellular junction complexes by EGTA improves viral infection efficiency in various tissues and polarized cell cultures. 14,23,[25][26][27][28] Transient depletion of extracellular calcium may overcome the inefficiency of baculovirus-mediated gene transfer by disassociating paracellular epithelial junction complexes and exposing the basolateral surface. We hypothesized that in normal medium, which contains calcium, the baculovirus binds and delivers its genome only to peripheral cells and baculovirus attachment, and entry to internal cells is prevented because paracellular junctions mask the baculovirus binding motif of these internal hepatocytes.…”
Section: Introductionmentioning
confidence: 99%
“…Receptor expression also differs with regards to the location on the cell membrane. For instance, the receptor for adenovirus serotype 5 (the coxsackie and adenovirus receptor CAR) is expressed apically in mice (and thus easily accessible to topical vector delivery), but basolaterally in humans [48,49]. This disparity in receptor distribution likely underpins the failure of rAd in human trials to deliver on the early successes in murine studies.…”
Section: A Brief History Of In-vivo Gene Therapymentioning
confidence: 99%